Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | — | 53.2M | 33.8M | 29.4M |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | 13.6M | 6.9M | 6.0M |
| Other operating expenses | — | 1.2M | 0 | 0 |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | — | 16.3M | -389.6M | 9.1M |
| Tax provision | — | -1.6M | -41.1M | 315K |
| Net income | — | 17.9M | -348.5M | 8.8M |
| Basic EPS | — | — | -908.6 | 15.5 |
| Diluted EPS | 0.0 | — | -908.6 | 15.5 |
| Basic average shares | — | — | 383.5K | 564.2K |
| Diluted average shares | — | — | 383.5K | 564.2K |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |